Green Tea Consumption and Liver Disease

Xi Jin; Ruo-heng Zheng; You-ming Li

Disclosures

Liver International. 2008;28(7):990-996. 

In This Article

Abstract and Introduction

Objectives: To present the effect of green tea consumption against liver disease.
Data sources: Interventional and observational studies both in Western countries and in China and published between the years 1989 and December 2007.
Review Methods: The articles were retrieved from Medline, Embase database, Chinese biomedicine web database and Chinese scientific journal's database using proper MESH headings and assessed by two independent investigators according to established inclusion criteria. The characteristics and outcomes of the chosen articles were displayed for further analysis and the quality of each study was also evaluated according to the widely acknowledged criteria. P<0.05 was defined as statistically significant in all enrolled trials.
Results: Ten qualified studies (eight from China, one from Japan and the other from the USA) with various outcomes such as liver cancer, cirrhosis and fatty liver disease were finally chosen. Among them, study designs differed in that there were four randomized-controlled clinical trials, two cohort, one case-control and three cross-sectional studies. The heterogeneity in the study design, outcomes, cofounders and amount of tea consumption precluded further meta-analysis. Nevertheless, eight studies showed a significant protective role of green tea against various liver diseases as determined by relative risk/odds ratio or P-value and among them, four studies showed a positive correlation between green tea intake and attenuation of liver disease. Moreover, the other two studies also presented the protective tendency of green tea against liver disease.
Conclusions: An increased consumption of green tea may reduce the risk of liver disease.

Tea and coffee are two of the most widely consumed beverages around the world, and the origin of green tea could be dated back to the Han dynasty in China (around 200 BC). Although the protective effect of green tea on human health has been widely acknowledged, the underpinning mechanisms are still vague. Not until recently has the mystery of green tea been gradually unveiled. Based on data from cell biology and animal experiments, green tea was proved to have anticarcinogenetic,[1,2] antioxidative,[3] lipid-lowering[4,5] and other biological activities,[6] which are thought to be beneficial to human beings.

Triggered by these breakthroughs, investigations involving the effect of green tea on humans have been undertaken and some results have already been summarized by meta-analysis.[7,8,9,10,11,12] Although, the evidence on the association between green tea consumption and liver diseases has not yet been summarized, previous works on animal models have supported a protective effect of green tea against liver injury and disease.[13,14,15] Inspired by the findings from Larsson and Wolk,[16] that an increased consumption of coffee may reduce the risk of liver cancer, we performed a systematic review to present the association between green tea consumption and liver diseases from both interventional and observational studies. Heterogeneity in methodologies and reporting qualities precluded further application of meta-analysis, that would provide a summary estimation of different results.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....